Doctors have hailed “unprecedented” trial results that show a triple-action cancer jab can eradicate entire tumours in patients.
In an international trial spanning 11 countries, the injection was offered to patients whose cancer had spread or come back and whose disease had failed to respond to other treatments.
The jab, called amivantamab, shrank the tumours of more than a third of patients, with dramatic changes seen within weeks. In 15 of them, doctors found the drug had melted away their tumours altogether.
Kevin Harrington, professor in biological cancer therapies at the Institute of Cancer Research, London (ICR), said: “These are unprecedentedly strong responses in patients whose disease has become resistant to both chemotherapy and immunotherapy.
23 Comments
Casterial@lemmy.world · 40 pts · 114d
It'll cost $55000 in the US and $5 everywhere else
Onyxonblack@piefed.social · 17 pts · 114d
You have to be joking right?? It'll cost literally millions of dollars per jab here in the ol' divided states of america.
Casterial@lemmy.world · 4 pts · 113d
$55,000 if you donate to your favorite candidate (Republican) of course! /S
jet@hackertalks.com · 3 pts · 112d
No no, they will play with the formula so it doesn't cure in a single jab but stabilizes it... So you need to take maintenance jabs every week.
Recurring revenue!
AwesomeLowlander@sh.itjust.works · 3 pts · 113d
And the govt will cover that $5 in some countries.
FlashMobOfOne@lemmy.world · 31 pts · 114d
Some wild, but positive, news this morning.
homesweethomeMrL@lemmy.world · 6 pts · 114d
I’ll take it. Thank you.
mierdabird@lemmy.dbzer0.com · 21 pts · 114d
It is bizarre to see a presumably serious article repeatedly use the term "jab" for a medical procedure. It's an antivaxxer trope and really doesn't belong anywhere near a scientific discussion
Viking_Hippie@lemmy.dbzer0.com · 30 pts · 114d
In the US, sure, but in the UK, it's been the main "jocular yet not unprofessional" term for decades, with neither negative nor positive connotations.
Just like how the majority of their biggest tabloid headlines are puns. British journalists are just built different for better and for worse 🤷🏻
imetators@lemmy.dbzer0.com · 2 pts · 112d
Checks out. The only times I hear term "jab" is when I talk to people from UK.
AwesomeLowlander@sh.itjust.works · 6 pts · 113d
Americentrism strikes again
quick_snail@feddit.nl · 3 pts · 113d
Nah, all of us who were very happy to get the vaccine proudly said "we got the jab"
Maybe antivaxxers then tried to claim it, but the first round of folks prioritized for the vaccine (eg healthcare workers) used it in a positive way first
BarneyPiccolo@lemmy.today · 3 pts · 113d
I once got set straight when I got offended when a European referred to something I was doing as a "scheme," which has nefarious connotation in America, but simply means "a plan" everywhere else.
mintiefresh@piefed.ca · 21 pts · 114d
Oh this sounds like really good news. I could use some good news for once.
MightEnlightenYou@lemmy.world · 11 pts · 114d
I wonder how long it'll be before this becomes the primary treatment. I sure know that I'd prefer this over the other options even if the odd were slightly worse
OrteilGenou@lemmy.world · 10 pts · 113d
I can't wait to never hear about this ever again
BarneyPiccolo@lemmy.today · 2 pts · 113d
It does seem like we see these stories, and then never hear about them again. On the other hand, we get assaulted by pharmaceutical ads constantly, so they seem to be coming up with plenty of new stuff.
They came up with all these new fat drugs, and just a few years ago I would have scoffed that anything like that would ever exist.
Atelopus-zeteki@fedia.io · 9 pts · 114d
Amivantamab (monoclonal antibody) is mentioned at least twice in the congress materials below.
Congress Materials – American Society of Clinical Oncology (ASCO 2026) https://www.jnjmedicalconnect.com/therapeutic-areas/oncology/congress/asco-2026
https://www.cancernetwork.com/view/amivantamab-regimen-boosts-survival-in-egfr-nsclc-subtype
https://www.ajmc.com/view/amivantamab-plus-folfox-folfiri-demonstrates-strong-durable-activity-in-mcrc
crusa187@lemmy.ml · 5 pts · 114d
Very promising, this is great news!
BarneyPiccolo@lemmy.today · 5 pts · 113d
I just saw a story on a new drug that works wonders on pancreatic cancer, which is particularly deadly, doubling life expectancies, and may work on other cancers as well. Hopefully, they'll start combining these drugs, and we'll see a huge improvement in outcomes.
LodeMike@lemmy.today · 2 pts · 113d
From birth or diagnosis?
BarneyPiccolo@lemmy.today · 2 pts · 112d
Diagnosis, but they have people living over a year longer, with a cancer that usually kills in months or even weeks.
derAbsender@piefed.social · 3 pts · 112d
Is that the one the cubans developed?